Dynavax Technologies Corp. DVAX

NAS: DVAX | ISIN: US2681582019 3/07/2025

10,27 USD (+1,08%)

(+1,08%) 3/07/2025

Grafiek Dynavax Technologies Corp.

Grafiek Dynavax Technologies Corp.

1 dag1d 1,08%
1 week1w 3,53%
1 maand1m 3,22%
3 maanden3m -17,77%
6 maanden6m -19,51%
1 jaar1j -8,71%
5 jaar5j 21,25%

Dynavax Technologies Corp. in het nieuws

Toon enkel gratis nieuws

12 mei 2025 · Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value · Persbericht

10 mei 2025 · /C O R R E C T I O N -- Dynavax Technologies/ · Persbericht

7 mei 2025 · Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum · Persbericht

6 mei 2025 · Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs · Persbericht

1 mei 2025 · Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits · Persbericht

29 april 2025 · Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy · Persbericht

22 april 2025 · Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 · Persbericht

17 april 2025 · Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders · Persbericht

3 april 2025 · Dynavax Files Preliminary Proxy Statement · Persbericht

6 maart 2025 · Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase · Persbericht

Profiel Dynavax Technologies Corp.

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.dynavax.com

Hoofdzetel: Emeryville, California Verenigde Staten

CEO: Ryan Spencer

Werknemers: 344

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe